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The main objective of immunology is to establish why and when
an immune response occurs, that is, to determine a criterion of
immunogenicity. According to the consensus view, the proper
criterion of immunogenicity lies in the discrimination between self
and nonself. Here we challenge this consensus by suggesting a
simpler and more comprehensive criterion, the criterion of conti-
nuity. Moreover, we show that this criterion may be considered as
an interpretation of the immune ‘‘self.’’ We conclude that immu-
nologists can continue to speak of the self, provided that they
admit that the selfnonself discrimination is not an adequate
criterion of immunogenicity.
continuity  self  nonself  tolerance
The main objective of immunology is to establish why andwhen an immune response occurs, that is, to determine a
criterion of immunogenicity. Since the 1950s a consensus has
formed on the acceptance and the adjustment of Burnet’s
seminal ideas (1, 2). According to this consensus, the proper
criterion of immunogenicity is the discrimination between self
and nonself (3). The central mechanism of any immune system
is allegedly the recognition of what is foreign: every element that
distinctively belongs to the organism does not trigger an immune
response, whereas every foreign element triggers an immune
response (4).
Yet this consensus is illusory, because experimental data accu-
mulated in the last two decades have put the selfnonself criterion
(SNC) into question. Unsurprisingly, this criterion has been criti-
cized both conceptually (5–7) and experimentally (8–10). However,
no consensus has emerged on a new, more convincing criterion.
Here, after a presentation of the experimental data that question
the SNC, we suggest the adoption of another, both simpler and
more comprehensive, criterion: the criterion of continuity (CC).
According to our hypothesis, an immune response is triggered not
by every foreign entity, but by every strong discontinuity of the
antigenic patterns (whether endogenous or exogenous) with which
immune receptors interact. In otherwords, the immune systemdoes
not respond to nonself, but rather to abrupt modifications of the
antigenic patterns with which it is in contact.
We conclude that the self can still be considered as the
object of immunology, but no longer as a proper criterion of
immunogenicity.
Experimental Challenge of the SNC
Although the concepts of self and nonself are widely considered
as central in immunology, no unique and clear-cut definition of
these concepts has ever been suggested (6, 7). Three definitions
have coexisted since Burnet: (i) the self conceived as the genome
of the organism, (ii) the self as the sum of all phenotypic
constituents originating from the genome of the organism, and
(iii) the self as the sum of the peptides that were not recognized
during selection, typically thymic selection. As we shall see, the
SNC cannot be grounded in any of these definitions. Contrary to
what the SNC asserts, self constituents commonly trigger im-
mune responses, and many foreign (nonself) entities do not
trigger immune responses.
Self Constituents Commonly Trigger Immune Responses. During the
selection of lymphocytes in primary lymphoid organs (thymus
for T lymphocytes and bone marrow for B lymphocytes), cells
that react strongly with antigenic patterns displayed by antigen-
presenting cells and those that do not react at all with these
patterns are deleted. Hence, weak reaction to self constituents
is a necessary condition of lymphocytic survival in primary
lymphoid organs (11). Furthermore, this selection continues
throughout the lifetime of the organism: in peripheral organs
(spleen, lymph nodes, etc.), circulating lymphocytes that do not
react with self antigens die (12). Collectively, these data show
that reactions with self constituents are not merely a possibility,
but a necessary condition for an efficient immune system. In
normal conditions, therefore, the immune system reacts con-
stantly (and weakly) with the constituents of the body. None-
theless, there is a difference between immune reaction and
immune response: an immune ‘‘reaction’’ refers to the interac-
tion between immune receptors and antigenic patterns, whereas
there is an immune ‘‘response’’ when the interaction (reaction)
leads to the activation of immune cells, that is, to the triggering
of effector mechanisms. It might therefore be tempting to say
that a good definition of the self has been reached: the self would
be conceived of as the set of molecular patterns that trigger weak
immune reactions, but no response. Self-reactions, however, are
not limited to continuous interactions between immune cells and
normal, endogenous components of the body. The actual acti-
vation, by self components, of immune cells and molecules
commonly occurs, as illustrated by two examples. The first
example is the phagocytosis of cells that undergo changes in their
patterns, particularly dying cells: they are genetically and phe-
notypically self cells, but they are recognized as entities to be
destroyed and trigger immune effector functions (13). The
second example concerns regulatory T cells (TReg), which
respond to other, normal lymphocytes by down-regulating their
activation. TReg, which are involved in the balance of autoim-
munity, in tolerance of tumors, etc. (14), are self cells (in all of
the possible senses of the term) that respond to other self cells.
Collectively, these data illustrate the fact that the immune system
is a set of homeostatic processes in which reactions with self
components are indispensable and involve most of the time
effector mechanisms similar to those responsible for responses to
pathogens.
Many Foreign (Nonself) Entities Do Not Trigger Immune Responses.
Immune tolerance is certainly not a new idea, but what has been
admitted increasingly within the last decade is the diversity and
the ubiquity of tolerance mechanisms. All multicellular organ-
isms contain massive quantities of foreign elements that do not
trigger immune responses. These include the following:
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1. Bacteria. Many bacteria live in multicellular organisms with-
out inducing immune responses, and, in some cases, they are
even beneficial to the host, especially on the mucosal surfaces
(lungs, gut, sensory organs, and organs of reproduction). The
gut is thought to be colonized by 1014 commensal microor-
ganisms, which contribute to the defense of the host and to
its digestive capacity (15, 16). In many organisms, commensal
bacteria are even indispensable for the development of an
efficient immune system (17, 18).
2. Protozoan parasites and parasitic worms (helminths). Para-
sites display, most of the time, large quantities of antigens at
their surface, and yet in many cases they induce no immune
response at all (e.g., Trypanosoma cruzi) (19).
3. Fetus. In the great majority of cases, although its genome is
semidifferent from that of the mother, the fetus does not
trigger any maternal immune response or is protected against
such a response. Induction of tolerance mechanisms, such as
those due to HLA-G (20) and TReg (21), have been proved
to play a critical role in this tolerance.
4. Chimerism. Chimerism is the process by which some cells are
exchanged between two organisms and maintained in at least
one of them, even though they are foreign to the host. The
most striking example is fetomaternal chimerism: in humans,
components originating from the child have been found in the
mother up to 27 years after delivery (22).
In all of these cases, the immune system does not simply ignore
the antigens, but rather it actively tolerates them. In other words,
immune receptors interact with the antigens involved, but this
interaction does not lead to a destructive response.
Thus, whatever definition of self one may favor, the criterion
of immunogenicity sought by immunologists cannot be the SNC:
many self components induce immune responses, whereas many
nonself components do not. Of course, every scientific hypoth-
esis, especially in life sciences, faces some exceptions; but it is
worth asking the question, how many exceptions are needed to
start to question the hypothesis itself? Our view is that the SNC
is currently challenged by too many exceptions to remain unal-
tered. We believe that the immune system simply does not
discriminate between self and nonself, although it may contrib-
ute to define the self (discussed in Conclusion: Should We
Abandon the SelfNonself Language in Immunology?).
Situation of Contemporary Immunology
With regard to these data, contemporary immunologists may
adopt several different attitudes. The first attitude is to maintain
the SNC. This option demands a new consensus, both on the
definition of the concepts of self and nonself and on the
mechanism of selfnonself discrimination, a new consensus that
is clearly missing today (23). A second attitude is to say that
immunology should not seek a criterion of immunogenicity or a
theory anymore and should focus only on experimental work
(24). Yet this option is unsatisfying, for experimental data make
sense only within a theoretical framework. A third attitude,
which, although rarely made explicit, is quite common among
immunologists, is to define the self as that which does not trigger
an immune response and the nonself as that which triggers an
immune response (25). Yet this option is a vicious circle, because
it does not offer a criterion of immunogenicity, but only a name
for an observed phenomenon. Indeed, this option offers no
prediction and no explanation.
The difficulty comes from the fact that no scientific hypothesis
can be called into question unless another, more convincing view
emerges. Here we suggest a very simple and comprehensive
criterion around which immunologists may rally.
Our Suggestion: The CC
Principle of the CC. The SNC is closely interlinked with the view
that an organism results from the unfolding of its inner charac-
teristics, i.e., the idea that an organism is the set of the
constituents (cells, molecules) originating from its genome. The
SNC sees the immune system as defending the integrity of these
endogenous constituents, which compose the organism. The
criterion for the definition of the organism is in this case the
opposition between the endogenous (what comes from the inside
of the organism, that is, the products of its genome) and the
exogenous (what comes from the outside of the organism and
cannot be part of it). Therefore, we understand how the immu-
nological SNC continues this general conception of the organ-
ism: the immune system enables the organism to exclude and
destroy everything that is different from itself, that is, everything
that does not come from the ‘‘inside.’’
According to the CC, an effector immune response is indeed
due to an antigenic difference, but not a difference between the
endogenous (self) and the exogenous (nonself). The CC goes
back to the antigenic difference itself, without interpreting it a
priori as a difference between self and nonself. Therefore, if the
CC is correct, immunologists have been perfectly right to
account for the triggering of the immune response with antigenic
difference, but they have improperly interpreted it as a differ-
ence in origins (endogenous vs. exogenous), whereas it is only the
structural (molecular) difference that is important. Here is
indeed the principle of the CC: every effector immune response
is due to a strong antigenic discontinuity, that is, to the appear-
ance in the organism of antigenic patterns (epitopes) that are
different from those with which immune receptors continuously
interact. The immune receptors are those of lymphocytes, den-
dritic cells, macrophages, etc. The antigenic patterns are the
epitopes to which immune receptors bind. They can be either
exogenous (pathogenic patterns, alloantigens expressed on a
transplanted organ, etc.) or endogenous (tumor markers, pat-
terns expressed on apoptotic cells, patterns recognized by TReg,
etc.) Finally, an immune response is not simply an immune
biochemical interaction between immune receptors and anti-
genic patterns, it is the actual triggering of effector mechanisms
(destruction or neutralization of the antigen, up-regulation or
down-regulation of other immune components). If the CC is
correct, an immune response occurs when the antigens with
which immune receptors interact are very different from those
with which they usually interact (antigenic discontinuity). In
other words, an immune response is induced by the sudden
appearance of epitopes that are unusual, that is, strongly differ-
ent from those with which immune receptors repeatedly interact
and which remain the same or change very slowly. Immune
receptors interact strongly with these abnormal epitopes, that is,
with a strong affinity andor specificity.
According to the CC, for a given organism, epitopes are
immunogenic if they are unusual, but this does not imply that
they are necessarily new: in the case of immune memory (for B
and T cells), some immune receptors selected previously respond
strongly to epitopes that have already been encountered but with
which immune receptors have not continuously interacted ever
since.
By speaking of strong discontinuity, the CC takes into account
(i) the quantities of the antigen. Very small quantities of antigens
do not induce an immune response. (ii) The degree of molecular
difference between the new antigen and the antigens with which
immune receptors constantly interact. There is no immune
response when the antigens with which immune receptors cur-
rently interact are the same or almost the same as those with
which immune receptors repeatedly interact. They are exactly
the same in the case of the normal functioning of an immune
system or when there is a perfect molecular resemblance be-
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tween the two antigens (e.g., acceptance of grafts between two
identical twins, or acceptance of autografts). They are almost the
same, for instance, in the case of efficient molecular mimicry
(e.g., T. cruzi) (26). (iii) The speed of the appearance of the
unusual antigenic patterns. In some cases, an antigen introduced
very progressively in an organism induces tolerance, not a
destructive response. Similarly, when an antigen (whether en-
dogenous or exogenous) present in an organism undergoes very
slow mutations and hence slight phenotypic modifications of its
surface epitopes, no immune response is triggered. On the other
hand, extremely rapid changes of epitopes (as happens with some
pathogens) induce no immune response either, because no
specific response can be mounted by the immune system. Thus,
there is a window of activation as far as the speed of antigenic
discontinuity is concerned: very slow changes do not induce an
immune response, and very fast ones do not either; only changes
of intermediate speed induce an immune response.
Thus, the CC does not say that every modification, every
antigenic discontinuity, induces an immune response. To get an
immune response, a strong discontinuity (estimated according to
three criteria: quantities of antigens, molecular difference with
usual antigens, and speed of antigenic modification) is required.
Induction of Tolerance by Induction of Continuity. The CC says that
the adequate criterion of immunogenicity lies in the break of
antigenic continuity. But it also allows us to understand in which
conditions a new antigenic continuity is established, that is, how
a new antigen (i.e., molecularly different from those with which
the immune system continuously interacts) is integrated among
the normal, usual antigens of the organism without inducing an
effective immune response. This integration process relies on
induction of continuity. There is induction of tolerance by
induction of continuity when repeated contacts with a new
antigen under nonimmunogenic (weak quantities of antigen and
progressive antigenic modifications) and nondestructive (no
damage to the tissues of the organism) conditions occur. In this
case, the probability of triggering an immune response decreases
progressively; in other words, the antigen is progressively toler-
ated by the immune system (which, by a ‘‘habituation’’ process,
gets ‘‘used’’ to the presence of this antigen). Induction of
continuity implies the tolerogenic activity of regulatory compo-
nents, the role of which is now well established, particularly for
dendritic cells (27, 28), TReg (29), and especially those induced
at the periphery (30), the HLA-Gmolecule of histocompatibility
(31), or even several of them collaborating (32). We believe that
better tolerance of a graft if antigens from the donor are injected
before the transplantation (33), the efficiency of negative vac-
cination (i.e., the stimulation of TReg to progressively obtain a
reduced immune response), temporary tolerance to paternal
alloantigens during pregnancy (34), fetomaternal tolerance,
fetomaternal chimerism, induction of tolerance in tumor cells,
some kinds of tolerance to pathogens (especially to some par-
asites), and more generally the creation of tolerogenic micro-
environments (30) could all be examples of induction of conti-
nuity. Induction of continuity is also consistent with immune
exhaustion: T cells, for instance, can be exhausted after a long
contact with the antigen, particularly with persistent pathogen,
like in LCMV infection (35, 36). In such a case, the immune
system progressively ceases to respond to persisting antigens.
Why Should We Adopt the CC? Several data tend to prove that the
CC is a better criterion than the SNC.
1. Regulation of immunity: the functioning of the immune
system as an homeostasis. The CC subsumes under a unique
explanation the phagocytosis of dead or abnormal cells and
immune reactions to pathogens: in each case, it is the
discontinuity in the molecular patterns displayed on the cell
surface that triggers an immune response. Evidence for this
discontinuity in dead cells is particularly clear (37). Normal
autoreactivity, that is, the necessity for immune cells to be
stimulated constantly by endogenous components, and the
role of regulatory cells (especially TReg) are equally ex-
plained. This last case is particularly striking: whereas the
SNC has great difficulty in explaining the triggering of TReg
(which can respond to self as well as to nonself), there is no
such difficulty with the CC. TReg respond to a strong
discontinuity in the interactions between their receptors and
the epitopes with which they react (whether self or nonself),
exactly like the other immune cells do.
2. Tumor cells. Tumor cells, except perhaps those due to
oncogenic viruses, are self cells, insofar as they come from the
genome of the individual and are components of the organ-
ism. According to the CC, in many circumstances tumor cells
trigger an immune response because the molecular patterns
they display change considerably and this change thus con-
stitutes an antigenic discontinuity. Changes in tumor cells are
indeed very different from changes in normal cells: the
genome of normal cells is most of the time stable whereas
cancer cells undergo multiple genetic alterations; the tran-
scriptome in normal cells is stable, whereas cancer cells are
characterized by a major epigenetic instability; no tissue
invasion occurs with normal cells, whereas there is invasion
and metastasis with cancer cells; normal cells have a stable
pattern of cytokine and growth factor expression, in contrast
to cancer cells, which have an abnormal expression of cyto-
kines and growth factors (38).
3. Immunogenic mutations. Genetic changes can, by themselves,
elicit autoimmunity and tumor immunity when expressed in
inflammatory environments (39).
4. Tolerance of pathogens, such as commensal bacteria or
some parasites. These pathogens, especially when they do
not harm the organism and even play a useful role (example:
bacteria in the gut facilitate digestion), induce, by progres-
sive induction of continuity, a state of tolerance (40).
Leishmania major actively induces IL-10-producing TReg,
and these TReg prevent the clearance of the parasite by
other immune cells (41).
5. Fetomaternal tolerance and chimerism. As suggested previ-
ously, in this case induction of tolerance (42) may be realized
by induction of continuity.
Thus, the CC attempts to give an account of phenomena that
the SNC does not explain, or explains only by using ad hoc
hypotheses. The CC is simpler than the SNC because continuity
is measurable. Moreover, it is more comprehensive: it includes
autoreactivity, particularly regulatory components such as
TReg, and processes that imply immune constituents and yet do
not come within defense of integrity, but rather within ho-
meostasis (phagocytosis of dying cells, regulation of inflamma-
tion, etc.).
Conclusion: Should We Abandon the SelfNonself Language
in Immunology?
Recent self-proclaimed ‘‘revolutions’’ in immunology have not
compelled recognition among immunologists, partly because of
overstatements (25) and partly because of experimental inade-
quacies (24). By contrast, we propose to take a moderate line,
that is, to keep the language of self in immunology, but to try to
clarify its meaning.
Immunology is undoubtedly about the self, insofar as it focuses
on the persistence and cohesiveness of organisms. Indeed, immu-
nology’s main question is: what entities are accepted by an organ-
ism, and therefore may be considered as constituents of this
organism, and what entities are rejected? Thus, if the self is
regarded as a synonym of ‘‘organism,’’ then the immunological self
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language will be maintained. Yet two clarifications are to be kept
in mind: (i) The self is best seen as the product of immune
interactions, not as the basis and the cause of immunogenicity. The
immune system does not discriminate between endogenous and
exogenous entities, and consequently the SNC cannot be main-
tained. Our suggestion is that the CC offers a proper mechanism of
immunogenicity, which results in a definition of the immune self.
(ii) If the concepts of self and nonself are maintained as a criterion
of immunogenicity, they may well be misleading. In the last decade
it took a long time for the great majority of immunologists to
recognize the importance of some data, e.g., normal autoreactivity,
the role of regulatory cells (‘‘rediscovered’’ in the 2000s) (43), or
new tolerance mechanisms (20). Even today, some perspectives
might be concealed by the self language, if unclarified. Words do
matter in experimental science, and if self and nonself are still
considered as the basis of immunogenicity, this may impede im-
provements in immunology.
If seen as a proper interpretation of the immune self, the CC
may be a good way of maintaining the language of self without
being prone to the problems of the SNC.
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